JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 31, 2007; DOI: 10.1124/jpet.107.123695


This Article
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow All Versions of this Article:
jpet.107.123695v1
jpet.107.123695v2
324/1/196    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Gregory W. Sawyer
Frederick J. Ehlert
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawyer, G. W.
Right arrow Articles by Shults, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawyer, G. W.
Right arrow Articles by Shults, C. A.


Received for publication April 2, 2007.
Revised May 29, 2007.
Accepted for publication May 30, 2007.

Cysteine Pairs in the Third Intracellular Loop of the Muscarinic M1 Acetylcholine Receptor Play a Role in Agonist-Induced Internalization

Gregory W. Sawyer 1*, Frederick J. Ehlert 2, Crystal A. Shults 1

1 Oklahoma State University 2 University of California, Irvine

* Address correspondence to: E-mail: gregory.sawyer{at}okstate.edu

Abstract

We determined the functional role of a small domain in the third intracellular loop of the human muscarinic M1 (hM1) receptor. Using site-directed mutagenesis, several mutant hM1 receptors were made possessing either a deletion or point mutations within the third intracellular loop domain 252-PETPPGRCCRCC-263. Wild-type and mutant hM1 receptors were transiently expressed in CHO cells and the effects of each mutation on radioligand binding, agonist-mediated phosphoinositide hydrolysis, and agonist-induced internalization were determined. The mutant receptors exhibited a modest reduction in affinity for [3H]N-methylscopolamine (pKD = ~9.0) and a moderately increased binding capacity relative to the wild-type receptor (pKD = 9.57 ± 0.07). This moderate increase in binding capacity was associated with small increases in the maximal response and potency of carbachol for eliciting phosphoinositide hydrolysis through the mutant receptors (pEC50 = ~5.5) relative to wild-type (pEC50 = 5.35 ± 0.05). In contrast, carbachol-induced internalization of mutant hM1 receptors possessing either CC259-260AA or CC262-263AA, or both, double point mutations was significantly reduced when compared to the wild-type hM1 receptor. Of the hM1 receptor mutants tested, those possessing a CC262-263AA double point mutation had the least extensive carbachol-induced internalization. The desensitization and downregulation of receptors possessing this Cys/Ala double point mutation was similar to that observed for the wild-type hM1 receptor. Collectively, these observations suggest that Cys pairs 259-CC-260 and 262-CC-263 play an important role in the agonist-induced internalization of hM1 receptors.


Key words: Cysteines, Desensitization, Internalization, Muscarinic, Mutagenesis, Receptors





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.